Norse is subleasing more aeroplanes( Photo: Cision)

Norse Atlantic Airways and Spanish airline Air Europa have signed a term sheet for the sublease of four aircraft, two Boeing 787-8s and two Boeing 787-9s. The agreement will generate positive cash flow for Norse and is for a period of 18 months.  

“This sublease agreement with Air Europa provides a compelling opportunity to generate positive cash flow from aircraft that we were not planning to fully utilize in our start-up phase. The agreement strengthens our already solid financial position as we continue to stay true to our strategy of cautiously entering the market and ramping up based on customer demand,” said Norse CEO Bjørn Tore Larsen. 

The aircraft will be delivered to Air Europa in the second quarter. The sublease is subject to completion of documentation, expected to occur around the end of April.

Norse commences ticket sales later this month and the first flight will take off in June. Norse plans to serve destinations including Oslo, Paris, London, New York, Los Angeles and Florida. The route network will be announced when ticket sales are launched.   

“We strongly believe that the demand for transatlantic travel will eventually bounce-back with full force because people will want to explore new destinations, visit friends and family and travel for business. Norse will be there to offer attractive and affordable flights on our more environmentally friendly and fuel-efficient Boeing 787 Dreamliners to both leisure and cost-conscious business travelers,” Larsen said.  


Investors: Chief Financial Officer Ben Boiling, 

Media: Chief Communications Officer Lasse Sandaker-Nielsen, 

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange release was published by Ben Boiling, CFO, Norse Atlantic ASA, on 12 April 2022 at 08:00 CET. 

This information was brought to you by Cision

Skriv en kommentar

Din e-postadresse vil ikke bli publisert. Obligatoriske felt er merket med *